According to a research presented at the 28th Annual Conference of the American Society for Laser Medicine and Surgery, a non-invasive laser procedure that uses laser-induced scatter and fluorescence measurements to detect a specific protein that accumulates in the brain and eyes of Alzheimer’s patients has shown favourable results in laboratory work. Alzheimer’s disease, which is the most common cause of dementia and the 12th leading cause of death in the U.S., is characterized by the accumulation of toxic deposits of the Beta-amyloid (BA) protein in the brain and in the eye lens.